Previous close | 319.43 |
Open | 318.83 |
Bid | 280.20 x 900 |
Ask | 325.00 x 1000 |
Day's range | 317.70 - 322.00 |
52-week range | 215.96 - 335.83 |
Volume | |
Avg. volume | 1,088,374 |
Market cap | 84.376B |
Beta (5Y monthly) | 1.67 |
PE ratio (TTM) | 16.82 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.64 (0.83%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | N/A |
Following incubation with HCA Healthcare EDs, Augmedix announces the general availability of Augmedix Go in emergency departmentsSAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the cou
BOSTON & NASHVILLE, Tenn. & ORANGE, Calif. & ATLANTA, April 23, 2024--An automated tool that improves outbreak detection for hundreds of pathogens successfully served as an early warning system to find and respond to potential hospital outbreaks, as reported today in NEJM Evidence.
NASHVILLE, Tenn., April 22, 2024--HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced it has been named on Fortune’s 2024 World’s Most Admired Companies list. This year, HCA Healthcare is ranked first overall in its industry.